Carnegie Investment Counsel’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,216
Closed -$207K 565
2026
Q1
$207K Buy
+4,216
New +$196K ﹤0.01% 542
2021
Q2
Sell
-10,094
Closed -$315K 479
2021
Q1
$315K Hold
10,094
0.01% 371
2020
Q4
$304K Hold
10,094
0.01% 361
2020
Q3
$257K Hold
10,094
0.01% 362
2020
Q2
$261K Hold
10,094
0.02% 360
2020
Q1
$265K Hold
10,094
0.02% 336
2019
Q4
$328K Hold
10,094
0.02% 352
2019
Q3
$348K Sell
10,094
-5,749
-36% -$193K 0.02% 337
2019
Q2
$542K Buy
15,843
+2,804
+22% +$99K 0.04% 296
2019
Q1
$466K Hold
13,039
0.03% 307
2018
Q4
$419K Buy
+13,039
New +$417K 0.04% 274
2018
Q3
Sell
-7,991
Closed -$247K 356
2018
Q2
$247K Hold
7,991
0.02% 345
2018
Q1
$232K Buy
7,991
+1
+0% +$27 0.02% 339
2017
Q4
$206K Sell
7,990
-28
-0.3% -$805 0.02% 365
2017
Q3
$227K Hold
8,018
0.03% 327
2017
Q2
$220K Buy
+8,018
New +$204K 0.03% 328
2017
Q1
Sell
-8,158
Closed -$207K 341
2016
Q4
$207K Buy
+8,158
New +$193K 0.03% 318
2013
Q4
Sell
-50,956
Closed -$1.08M 212
2013
Q3
$1.08M Buy
50,956
+6,148
+14% +$134K 0.33% 85
2013
Q2
$987K Buy
+44,808
New +$1.09M 0.32% 87

Other funds holding EXC

Carnegie Investment Counsel's EXC Position: Q2 2026 in Review

Carnegie Investment Counsel sold out of Exelon (EXC) in Q2 2026, closing a stake of 4,216 shares — an estimated $207K sold.

Carnegie Investment Counsel first reported a position in EXC in Q2 2013 and held it in 19 quarters. The position peaked at $1.08M in Q3 2013. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Carnegie Investment Counsel reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
  • Carnegie Investment Counsel sold 4,216 Exelon shares in Q2 2026, an estimated $207K.
  • Carnegie Investment Counsel first reported a position in Exelon in Q2 2013 and held it in 19 quarters.
  • Carnegie Investment Counsel's Exelon position peaked at $1.08M in Q3 2013.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.